{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:13:36Z","timestamp":1784052816401,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sichuan Nursing Association","award":["H24014"],"award-info":[{"award-number":["H24014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00520-026-10841-5","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:44:47Z","timestamp":1781192687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and practice of a standardized management pathway for chemotherapy-induced neutropenia in patients with gynecological malignancies"],"prefix":"10.1007","volume":"34","author":[{"given":"Xin","family":"Dan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaizhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"10841_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2024.102664","volume":"93","author":"Y Pag\u00e1n-Santana","year":"2024","unstructured":"Pag\u00e1n-Santana Y, Casta\u00f1eda-Avila M, R\u00edos-Motta R, Santos-Reyes L, Ortiz-Ortiz KJ (2024) Examining concordance with the guidelines of the National Comprehensive Cancer Network for the treatment of endometrial cancer in Puerto Rico. Cancer Epidemiol 93:102664. https:\/\/doi.org\/10.1016\/j.canep.2024.102664","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"10841_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10841_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.109606","volume":"51","author":"J Calleja-Agius","year":"2025","unstructured":"Calleja-Agius J, Gatta G, Sandrucci S (2025) Gynecological cancers: bridging the gap between research and cure. Eur J Surg Oncol 51(4):109606. https:\/\/doi.org\/10.1016\/j.ejso.2025.109606","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10841_CR4","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s00120-021-01569-7","volume":"60","author":"IM Zraik","year":"2021","unstructured":"Zraik IM, He\u00df-Busch Y (2021) Management von Nebenwirkungen der Chemotherapie und deren Langzeitfolgen [Management of chemotherapy side effects and their long-term sequelae]. Urologe A 60(7):862\u2013871. https:\/\/doi.org\/10.1007\/s00120-021-01569-7","journal-title":"Urologe A"},{"issue":"4","key":"10841_CR5","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.3390\/curroncol29040177","volume":"29","author":"H Suto","year":"2022","unstructured":"Suto H, Inui Y, Okamura A (2022) Predicting chemotherapy-related adverse events in elderly cancer patients with prior anticancer therapy. Curr Oncol 29(4):2185\u20132192. https:\/\/doi.org\/10.3390\/curroncol29040177","journal-title":"Curr Oncol"},{"key":"10841_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102427","volume":"109","author":"DW Blayney","year":"2022","unstructured":"Blayney DW, Schwartzberg L (2022) Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: a review. Cancer Treat Rev 109:102427. https:\/\/doi.org\/10.1016\/j.ctrv.2022.102427","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10841_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.tjog.2022.05.001","volume":"61","author":"YT Li","year":"2022","unstructured":"Li YT, Yang ST, Wang PH (2022) Chemotherapy adjuvant and chemotherapy-induced neutropenia. Taiwan J Obstet Gynecol 61(4):573\u2013574. https:\/\/doi.org\/10.1016\/j.tjog.2022.05.001","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10841_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/10732748231183496","volume":"30","author":"Y Xu","year":"2023","unstructured":"Xu Y, Wei M, Cheng X, Li X (2023) Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced epithelial ovarian carcinoma. Cancer Control 30:10732748231183496. https:\/\/doi.org\/10.1177\/10732748231183496","journal-title":"Cancer Control"},{"issue":"11","key":"10841_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08929-x","volume":"32","author":"N Scher","year":"2024","unstructured":"Scher N, Boudabous H, Partouche J et al (2024) Enhancing patient-centered care: a randomized study on G-CSF administration preferences in chemotherapy-induced neutropenia. Support Care Cancer 32(11):743. https:\/\/doi.org\/10.1007\/s00520-024-08929-x","journal-title":"Support Care Cancer"},{"issue":"3","key":"10841_CR10","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/cam4.4465","volume":"11","author":"MS Ven\u00e4l\u00e4inen","year":"2022","unstructured":"Ven\u00e4l\u00e4inen MS, Heerv\u00e4 E, Hirvonen O et al (2022) Improved risk prediction of chemotherapy-induced neutropenia-model development and validation with real-world data. Cancer Med 11(3):654\u2013663. https:\/\/doi.org\/10.1002\/cam4.4465","journal-title":"Cancer Med"},{"issue":"5","key":"10841_CR11","doi-asserted-by":"publisher","first-page":"436","DOI":"10.6004\/jnccn.2022.0026","volume":"20","author":"EA Griffiths","year":"2022","unstructured":"Griffiths EA, Roy V, Alwan L et al (2022) NCCN Guidelines\u00ae insights: hematopoietic growth factors, version 1.2022. J Natl Compr Canc Netn 20(5):436\u2013442. https:\/\/doi.org\/10.6004\/jnccn.2022.0026","journal-title":"J Natl Compr Canc Netn"},{"issue":"suppl 5","key":"10841_CR12","doi-asserted-by":"publisher","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","volume":"27","author":"J Klastersky","year":"2016","unstructured":"Klastersky J, de Naurois J, Rolston K et al (2016) Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol 27(suppl 5):v111\u2013v118. https:\/\/doi.org\/10.1093\/annonc\/mdw325","journal-title":"Ann Oncol"},{"issue":"1","key":"10841_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejca.2010.10.013","volume":"47","author":"MS Aapro","year":"2011","unstructured":"Aapro MS, Bohlius J, Cameron DA et al (2011) 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer 47(1):8\u201332. https:\/\/doi.org\/10.1016\/j.ejca.2010.10.013","journal-title":"Eur J Cancer"},{"issue":"28","key":"10841_CR14","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1200\/JCO.2015.62.3488","volume":"33","author":"TJ Smith","year":"2015","unstructured":"Smith TJ, Bohlke K, Lyman GH et al (2015) Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 33(28):3199\u20133212. https:\/\/doi.org\/10.1200\/JCO.2015.62.3488","journal-title":"J Clin Oncol"},{"issue":"6","key":"10841_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1208\/s12248-020-00529-x","volume":"22","author":"W Chen","year":"2020","unstructured":"Chen W, Boras B, Sung T, Hu W, Spilker ME, D\u2019Argenio DZ (2020) Predicting chemotherapy-induced neutropenia and granulocyte colony-stimulating factor response using model-based in vitro to clinical translation. AAPS J 22(6):143. https:\/\/doi.org\/10.1208\/s12248-020-00529-x","journal-title":"AAPS J"},{"issue":"1","key":"10841_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/bcp.15507","volume":"89","author":"X Huang","year":"2023","unstructured":"Huang X, Li S, Shi W et al (2023) A prospective, randomized clinical trial of emergency treatment of chemotherapy-induced neutropenia and febrile neutropenia by pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF). Br J Clin Pharmacol 89(1):372\u2013379. https:\/\/doi.org\/10.1111\/bcp.15507","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10841_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-025-02409-2","volume":"24","author":"Z Wang","year":"2025","unstructured":"Wang Z, Wang X, Chiu HC et al (2025) The people-centered care and inpatients\u2019 perceived experience in China: a nationwide cross-sectional study. Int J Equity Health 24(1):48. https:\/\/doi.org\/10.1186\/s12939-025-02409-2","journal-title":"Int J Equity Health"},{"issue":"Suppl 1","key":"10841_CR18","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","volume":"13","author":"S Cuschieri","year":"2019","unstructured":"Cuschieri S (2019) The STROBE guidelines. Saudi J Anaesth 13(Suppl 1):S31\u2013S34. https:\/\/doi.org\/10.4103\/sja.SJA_543_18","journal-title":"Saudi J Anaesth"},{"issue":"48","key":"10841_CR19","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.3760\/j:issn:0376-2491.2006.48.008","volume":"86","author":"YK Shi","year":"2006","unstructured":"Shi YK, He XH, Yang S et al (2006) Treatment of chemotherapy-induced neutropenia with pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase\u2161clinical study. Natl Med J China 86(48):3414\u20133419. https:\/\/doi.org\/10.3760\/j:issn:0376-2491.2006.48.008. (In Chinese)","journal-title":"Natl Med J China"},{"key":"10841_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.724620","volume":"11","author":"J Ni","year":"2021","unstructured":"Ni J, Cheng X, Zhou R et al (2021) Adverse events as a potential clinical marker of antitumor efficacy in ovarian cancer patients treated with poly ADP-ribose polymerase inhibitor. Front Oncol 11:724620. https:\/\/doi.org\/10.3389\/fonc.2021.724620","journal-title":"Front Oncol"},{"issue":"12","key":"10841_CR21","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1001\/jamaoncol.2017.1114","volume":"3","author":"K Patel","year":"2017","unstructured":"Patel K, West HJ (2017) Febrile neutropenia. JAMA Oncol 3(12):1751. https:\/\/doi.org\/10.1001\/jamaoncol.2017.1114","journal-title":"JAMA Oncol"},{"key":"10841_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40780-018-0130-2","volume":"5","author":"H Uda","year":"2019","unstructured":"Uda H, Suga Y, Toriba E et al (2019) Multiday corticosteroids in cancer chemotherapy delay the diagnosis of and antimicrobial administration for febrile neutropenia: a double-center retrospective study. J Pharm Health Care Sci 5:3. https:\/\/doi.org\/10.1186\/s40780-018-0130-2","journal-title":"J Pharm Health Care Sci"},{"key":"10841_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ygyno.2025.03.013","volume":"195","author":"AC Bujnak","year":"2025","unstructured":"Bujnak AC, Solaru SA, Tewari K (2025) Clinical applications of antibody drug conjugates for gynecologic malignancies: review of available medicines and emerging therapeutics. Gynecol Oncol 195:180\u2013191. https:\/\/doi.org\/10.1016\/j.ygyno.2025.03.013","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10841_CR24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1053\/j.semnuclmed.2024.01.003","volume":"54","author":"T Khessib","year":"2024","unstructured":"Khessib T, Jha P, Davidzon GA, Iagaru A, Shah J (2024) Nuclear medicine and molecular imaging applications in gynecologic malignancies: a comprehensive review. Semin Nucl Med 54(2):270\u2013292. https:\/\/doi.org\/10.1053\/j.semnuclmed.2024.01.003","journal-title":"Semin Nucl Med"},{"issue":"4","key":"10841_CR25","doi-asserted-by":"publisher","first-page":"896","DOI":"10.20892\/j.issn.2095-3941.2020.0069","volume":"17","author":"Y Ba","year":"2020","unstructured":"Ba Y, Shi Y, Jiang W et al (2020) Current management of chemotherapy-induced neutropenia in adults: key points and new challenges: Committee of Neoplastic Supportive-Care (CONS), China Anti-Cancer Association Committee of Clinical Chemotherapy, China Anti-Cancer Association. Cancer Biol Med 17(4):896\u2013909. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0069","journal-title":"Cancer Biol Med"},{"issue":"7","key":"10841_CR26","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1002\/2211-5463.13445","volume":"12","author":"K He","year":"2022","unstructured":"He K, Liu X, Hoffman RD, Shi RZ, Lv GY, Gao JL (2022) G-CSF\/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors. FEBS Open Bio 12(7):1268\u20131285. https:\/\/doi.org\/10.1002\/2211-5463.13445","journal-title":"FEBS Open Bio"},{"issue":"7","key":"10841_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/17474086.2022.2093712","volume":"15","author":"K Campbell","year":"2022","unstructured":"Campbell K, Chadha N, Dimri S, Wang W, Li E (2022) G-CSF primary prophylaxis use and outcomes in patients receiving chemotherapy at intermediate risk for febrile neutropenia: a scoping review. Expert Rev Hematol 15(7):619\u2013633. https:\/\/doi.org\/10.1080\/17474086.2022.2093712","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"10841_CR28","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.7108","volume":"22","author":"DH Hufnagel","year":"2024","unstructured":"Hufnagel DH, Bos LM, Brown AJ, Prescott LS (2024) Compliance with NCCN guidelines for evaluation and treatment of anemia among patients with solid tumors. J Natl Compr Canc Netw 22(3):e237108. https:\/\/doi.org\/10.6004\/jnccn.2023.7108","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10841_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cncr.11882","volume":"100","author":"J Crawford","year":"2004","unstructured":"Crawford J, Dale DC, Lyman GH (2004) Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer 100(2):228\u2013237. https:\/\/doi.org\/10.1002\/cncr.11882","journal-title":"Cancer"},{"issue":"31","key":"10841_CR30","doi-asserted-by":"publisher","first-page":"7974","DOI":"10.1200\/JCO.2004.00.7955","volume":"23","author":"JN Timmer-Bonte","year":"2005","unstructured":"Timmer-Bonte JN, de Boo TM, Smit HJ et al (2005) Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch randomized phase III study. J Clin Oncol 23(31):7974\u20137984. https:\/\/doi.org\/10.1200\/JCO.2004.00.7955","journal-title":"J Clin Oncol"},{"issue":"21","key":"10841_CR31","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1200\/JCO.2006.08.8823","volume":"25","author":"NM Kuderer","year":"2007","unstructured":"Kuderer NM, Dale DC, Crawford J, Lyman GH (2007) Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J Clin Oncol 25(21):3158\u20133167. https:\/\/doi.org\/10.1200\/JCO.2006.08.8823","journal-title":"J Clin Oncol"},{"issue":"2","key":"10841_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1524-4733.2007.00242.x","volume":"11","author":"A Eldar-Lissai","year":"2008","unstructured":"Eldar-Lissai A, Cosler LE, Culakova E, Lyman GH (2008) Economic analysis of prophylactic pegfilgrastim in adult cancer patients receiving chemotherapy. Value Health 11(2):172\u2013179. https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00242.x","journal-title":"Value Health"},{"issue":"2","key":"10841_CR33","doi-asserted-by":"publisher","first-page":"310","DOI":"10.17305\/bjbms.2022.7859","volume":"23","author":"W Li","year":"2023","unstructured":"Li W, Dong M, Huang S et al (2023) Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer. Biomol Biomed 23(2):310\u2013316. https:\/\/doi.org\/10.17305\/bjbms.2022.7859","journal-title":"Biomol Biomed"},{"issue":"1","key":"10841_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11198-2","volume":"23","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Zhang J, Zhong J et al (2023) Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients. BMC Cancer 23(1):702. https:\/\/doi.org\/10.1186\/s12885-023-11198-2","journal-title":"BMC Cancer"},{"key":"10841_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/BTT.S58597","volume":"10","author":"R Guariglia","year":"2016","unstructured":"Guariglia R, Martorelli MC, Lerose R, Telesca D, Milella MR, Musto P (2016) Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients. Biologics 10:1\u20138. https:\/\/doi.org\/10.2147\/BTT.S58597","journal-title":"Biologics"},{"issue":"14","key":"10841_CR36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2217\/fon-2020-0167","volume":"16","author":"M Danova","year":"2020","unstructured":"Danova M, Pronzato P, Ingrasciotta Y et al (2020) Recent advances in the management of chemotherapy-induced neutropenia: biosimilar granulocyte colony-stimulating factor use in Italy. Future Oncol 16(14):891\u2013897. https:\/\/doi.org\/10.2217\/fon-2020-0167","journal-title":"Future Oncol"},{"issue":"1","key":"10841_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-024-10597-w","volume":"24","author":"X Dan","year":"2024","unstructured":"Dan X, He YL, Huang Y et al (2024) Construction and evaluation of a cloud follow-up platform for gynecological patients receiving chemotherapy. BMC Health Serv Res 24(1):116. https:\/\/doi.org\/10.1186\/s12913-024-10597-w","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10841_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-025-06187-z","volume":"20","author":"W Chen","year":"2025","unstructured":"Chen W, Qin X, Yang H, Tan Z, Liu P (2025) Impact of cloud-based follow-up exercise prescription on knee function and quality of life in homebound patients post-total knee arthroplasty: a randomized controlled trial. J Orthop Surg Res 20(1):809. https:\/\/doi.org\/10.1186\/s13018-025-06187-z","journal-title":"J Orthop Surg Res"},{"key":"10841_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.864398","volume":"9","author":"L Tong","year":"2022","unstructured":"Tong L, Xiong S, Hou J et al (2022) Cloud follow-up in patients with cardiovascular implantable electronic devices: a single-region study in China. Front Cardiovasc Med 9:864398. https:\/\/doi.org\/10.3389\/fcvm.2022.864398","journal-title":"Front Cardiovasc Med"},{"key":"10841_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.nepr.2024.104158","volume":"80","author":"L Montejo","year":"2024","unstructured":"Montejo L, Fenton A, Davis G (2024) Artificial intelligence (AI) applications in healthcare and considerations for nursing education. Nurse Educ Pract 80:104158. https:\/\/doi.org\/10.1016\/j.nepr.2024.104158","journal-title":"Nurse Educ Pract"},{"issue":"1","key":"10841_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16066-z","volume":"23","author":"Y Wu","year":"2023","unstructured":"Wu Y, Min H, Li M et al (2023) Effect of Artificial Intelligence-based Health Education Accurately Linking System (AI-HEALS) for Type 2 diabetes self-management: protocol for a mixed-methods study. BMC Public Health 23(1):1325. https:\/\/doi.org\/10.1186\/s12889-023-16066-z","journal-title":"BMC Public Health"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10841-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10841-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10841-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:02:50Z","timestamp":1784052170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10841-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10841"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10841-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prior to enrollment, written informed consent was obtained from all participants. The study protocol received formal approval from the Hospital's Institutional Ethics Committee (Ethics Approval No. 2023251).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"644"}}